Preclinical
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Cancer Research UK, a cancer research and awareness charity in the United Kingdom and Isle of Man, recently announced its latest Grand Challenge winners. This cancer research grant awards a series of £20 million wards to international, multidisciplinary teams that focus on unique and new approaches to cancer.
Scientists at DZNE, the Hertie Institute for Clinical Brain Research (HIH) and the University Hospital Tuebingen identified a protein in blood that can precisely track Alzheimer’s disease progression before the first symptoms appear.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
The researchers identified a group of centyrins that blocked the action of five toxins generated by Staphylococcus aureus, the bacteria that causes Staph infections.
A study published in Clinical Chemistry earlier this month has linked sperm with more DNA damage to repeated miscarriages. Recurring miscarriages, defined as three or more consecutive miscarriages before 20 weeks of pregnancy, occur in 1-2 percent of couples.
The rate of incidence of infection by Naegleria fowleri in the U.S. is very, very low. But there’s something about picking up an incurable, brain-eating amoeba by swimming in freshwater lakes and rivers that understandably freaks people out.
After conducting a routine research-and-development review, Pfizer is easing away from preclinical biosimilar development. The bottom line is the company is ending five preclinical programs in its biosimilar area and cutting 150 positions.
Artificial intelligence technology has an established home in drug design for many developers. Now, researchers are seeing it as a potential tool in driving therapeutic choices in the treatment of ovarian cancer.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
PRESS RELEASES